Tag: investment
-
Janssen Licenses Biotech’s Antibody for Multiple Myeloma
Janssen Pharmaceutical Companies, a division of Johnson & Johnson in Horsham, Pennsylvania, agreed to license a cancer drug targeting multiple myeloma made by biotechnology company Genmab A/S in Copenhagen, Denmark. The agreement has a total potential value of $1.1 billion from upfront, milestone, and royalty payments, as well as an equity investment in Genmab. The…
-
Health Care Technology Accelerator Boosts Seed Funding
Rock Health, an organization that provides seed funding, training, and mentoring for start-up companies in health care technology, says its next class of companies will each receive a $100,000 investment. The funds for these start-ups are being provided by the Mayo clinic and three venture capital firms: Aberdare Ventures, Kleiner Perkins Caufield and Byers, and…
-
Medical Device Company Gets $20M in Venture Financing
Ornim Inc., a developer of blood oxygen and blood flow monitors in Lod, Israel, secured $20 million in series B venture funding, the second financing cycle after initial start-up. The round was led by life sciences investment firm OrbiMed, with participants including the GE healthymagination Fund and Agate Medical Investments LP. Ornim develops monitors focusing…
-
European Businesses Expect 4 Percent Annual R&D Growth
A survey of executives from larger companies in Europe shows the executives anticipate spending four percent more per year on research and development in the years 2012 to 2014. The report is based on responses from 187 executives conducted in January through April 2012 in companies that spent €56 billion, which makes up about 40…
-
Medical Monitor Device Start-Up Raises $7M in Venture Funds
Retia Medical, a medical device company in East Lansing, Michigan, raised $7 million in series A funds, the first round of financing after initial start-up. The Pritzker/Vlock family office, a private equity company investing in biotech, industrial and medical equipment, and technology businesses led the round. Retia Medical develops monitors for high-risk patients, starting with…
-
Breakout Labs Backs Tissue Engineering, Diagnostic Start-Ups
Breakout Labs, an early-stage revolving fund for life sciences start-ups, revealed three new grant recipients planning to develop solutions with advanced technologies. Breakout Labs is a program of the Thiel Foundation, founded by entrepreneur and investor Peter Thiel — co-founder of PayPal and early venture backer of Facebook — in October 2011. The new recipients…
-
Biopharm Raises $80 Million in Series C Venture Funds
Relypsa Inc., a clinical stage biopharmaceutical company in Santa Clara, California raised $80 million in series C venture funds, the third round of financing after initial start-up. New investor Sibling Capital LLC joins current backers OrbiMed Advisors, 5AM Ventures, New Leaf Venture Partners, Sprout Group, Delphi Ventures, and Mediphase Venture Partners in this funding round.…
-
Biotech Chemical Company Raises $41.5M in Venture Funds
Genomatica, a developer of chemicals from renewable feedstocks in San Diego, raised $41.5 million in series D financing, the fourth cycle of venture funding after start-up. The round includes the Italian chemical company and new corporate partner Versalis, with existing investors Alloy Ventures, Draper Fisher Jurvetson, Mohr Davidow Ventures, TPG Biotech, VantagePoint Capital Partners, and…
-
European Venture Volume Up, Science Company Investments Drop
Venture capital (VC) investment volume rose in the second quarter of 2012 compared to the second quarter of 2011, but the number of VC deals dropped sharply. The number and volume of investments in European science-based companies, says financial industry research service Dow Jones VentureSource, declined by double-digit percentages in the second quarter of 2012…
-
$2.6B Venture Fund Aims for Health Care, Energy Companies
New Enterprise Associates Inc., a venture capital company in Chevy Chase, Maryland, says it has closed its 14th fund with $2.6 billion in capital. New Enterprise says the new fund is its third consecutive property exceeding $2.5 billion, and brings the company’s total committed capital to more than $13 billion across all of its funds.…